Views & Analysis The future of healthcare: the patient advocate and investor ... Examining the views of different stakeholders in the ecosystem supporting drug R&D.
News NHS England confirms HIV prevention funding - but only via c... Large trial of HIV PrEP could lead to national programme
News ViiV to begin trials of HIV prevention injection GSK hopes patients will prefer PrEP injection to pills.
News Gilead's next gen HIV prevention trial to begin in UK UK hospital seeking ethical clearance for trial of Gilead's new PReP drug.
News NICE review sparks new call for HIV prophylaxis NICE review backs case for Truvada pre-exposure prophylaxis, say campaigners.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
